Predicting erectile dysfunction from prostate cancer treatment

Researchers identify DNA sequences that may determine ED following prostate radiation

2012-09-27

(Press-News.org) Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these patients in advance of treatment may better inform men and their families as to which prostate cancer treatments are best for their specific cancer and lifestyle, according to a study to be published online September 27, 2012, in advance of the October 1, 2012 print issue, in the International Journal of Radiation Oncology.Biology.Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). The findings could also guide doctors in recommending the most effective treatments that carry the least risk of patients developing ED.

The main treatments for prostate cancer—surgery, brachytherapy (seed implants) and external beam radiation therapy—are all very effective at curing prostate cancer. Unfortunately, each treatment places patients at risk for ED. Although many men will maintain their potency, doctors would like to identify which men are at greatest risk for the development of difficulty with sexual function.

In this multi-institutional, multi-national study, researchers from New York's Mount Sinai School of Medicine, Albert Einstein College of Medicine of Yeshiva University in Bronx, N.Y., New York University School of Medicine, Florida Radiation Oncology Group in Jacksonville, Fla., and Maastricht University Medical Center in Maastricht, the Netherlands, examined 593 men who were treated with brachytherapy and/or external beam radiation therapy and hormone therapy. Of them, 260 reported erectile dysfunction.

"Through a two-stage genome-wide association study, 12 single nucleotide polymorphisms (SNPs) were identified that were associated with the development of erectile dysfunction after radiation treatment for prostate cancer," said Barry S. Rosenstein, PhD, department of radiation oncology at New York's Mount Sinai Medical School. "If validated further, these SNPs could provide the basis for a blood test that would enable radiation oncologists to predict more accurately which men are most likely to develop erectile dysfunction after prostate cancer radiation therapy."

"Prostate cancer screening and treatment are undergoing major shifts," said Harry Ostrer, MD, professor of pathology and genetics at Albert Einstein College of Medicine, director of genetic and genomic testing at Montefiore Medical Center and co-principal investigator of the study. "This is part of our ongoing effort to personalize and optimize treatment for prostate cancer."

###Disclosures: One author (NS) reports to have received consulting fees or honoraria from Amgen, Ferring, Janssen, Diversified Conference Management, Prologics LLC, and Nihon MediPhysics. Another author (RS) has received fees for developing lectures and educational materials for Bard.

For complete text of the study, contact Michelle Kirkwood, 703-286-1600, press@astro.org. To learn more about the Red Journal, visit www.redjournal.org.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit www.rtanswers.org. To learn more about ASTRO, visit www.astro.org.

ELSE PRESS RELEASES FROM THIS DATE:

Possible link between infants' regulatory behaviors and maternal mental health

2012-09-27

Cincinnati, OH, September 27, 2012 – Functional somatic symptoms (FSS) are physical complaints, such as headaches, pain, fatigue, and dizziness, that cannot be explained medically. These symptoms affect 10-30% of children and adolescents and account for 2-4% of all pediatric doctor visits. A new study scheduled for publication in The Journal of Pediatrics finds that infants with regulatory problems (i.e., feeding, sleeping, and tactile reactivity) and/or maternal psychiatric problems may have an increased risk of FSS in later childhood. It is believed that maternal ...

Researchers find risk markers for erectile dysfunction following radiation in prostate cancer

2012-09-27

In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treated with radiation. The findings, to be published online September 27, 2012, in advance of the October 1, 2012 print issue in the International Journal of Radiation Oncology• Biology• Physics, the official scientific journal of the American Society for Radiation Oncology, are an important step towards ...

Research suggests shared genetic link in psychiatric and movement disorders

2012-09-27

WINSTON-SALEM, N.C. – Sept., 26, 2012 – Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible. RDP is caused by a genetic mutation (ATP1A3) that often runs in families. Now Wake Forest Baptist Medical Center researchers believe that same genetic predisposition might also be ...

Optical mammography sheds new light on breast cancer

2012-09-27

MEDFORD/SOMERVILLE, Mass. – New optical imaging technology developed at Tufts University School of Engineering could give doctors new ways to both identify breast cancer and monitor individual patients' response to initial treatment of the disease. A five-year clinical study of the procedure, funded by a $3.5 million grant from the National Institutes of Health, is now underway at Tufts Medical Center in Boston. The non-invasive technology uses near infrared (NIR) light to scan breast tissue, and then applies an algorithm to interpret that information. Differences in ...

Moffitt Cancer Center researchers find possible key to regulation of ovarian cancer stem cells

2012-09-27

Researchers at Moffitt Cancer Center have discovered that the micro ribonucleic acid miR-214 plays a critical role in regulating ovarian cancer stem cell properties. This knowledge, said the researchers, could pave the way for a therapeutic target for ovarian cancer. The study appears in a recent issue of the The Journal of Biological Chemistry. According to the study's lead author, Jin Q. Cheng, Ph.D., M.D., senior member of the Molecular Oncology Department and Molecular Oncology and Drug Discovery Program at Moffitt, certain miRNAs can cause therapeutic resistance ...

Glenn Prestwich at University of Utah to Speak at Modern Drug Summit Oct 24-26, 2012 in Philadelphia

2012-09-27

Glenn D. Prestwich, Presidential Professor, Director of Therapeutic Biomaterials Center, and Special Presidential Assistant for Faculty Entrepreneurism of Medicinal Chemistry at the University of Utah Will Give a Plenary Keynote Presentation on "Biomaterials for Regenerative Medicine: From Bench to Business" at the 8th Modern Drug Discovery & Development Summit (October 24-26, 2012 in Philadelphia, PA) Dr. Glenn Prestwich will describe the entrepreneurial ecosystem at the University of Utah as well as describe a case study for commercialization of a university ...

The Red Box of Frozen Yogurt: Industry CEOs Sweating Out the Rise of Robofusion?

2012-09-27

It's the kind of socially hip development that makes CEOs sweat. The kind of thing that one person mentions, then another, then another—and before the world knows it, an entire business model goes the way of the dinosaur while a rockstar replacement arises. Red Box did it in the movie rental business. Now Robofusion is doing it in the yogurt business, albeit coyly. "That's not something we can comment on at this time," said a high-ranking Robofusion employee on the condition of anonymity. "Red Box is an amazing product. We are flattered to be compared ...

Kelsey McBride PR Signs Author Paul Gillebaard

2012-09-27

Kelsey McBride, president of Kelsey McBride PR, officially announced today that Paul Gillebaard, author of Moon Hoax, signed on for her agency's public relations services. Charlie Duke, the 10th man on the moon, recently read Moon Hoax and said "I finally got around to reading Moon Hoax. It was a fantastic read. I could hardly put it down. Some twists and turns in the plot that I didn't expect. Thoroughly enjoyed it." In Moon Hoax, China claims the moon landings never happened and they have proof. Losing worldwide prestige is not an option for the United ...

Cedar Run Horse Park Prepares for Social Event of the Season

2012-09-27

The pace is set for another great adventure at Cedar Run Horse Park. More than 100 riders are expected at the 5th Annual Cedar Run Hunter Pace, the park's season finale scheduled for Saturday, September 29, and there's still time to be part of the action, says co-ordinator Elizabeth McCowan. "We'll be accepting registrations up to and including the day of the event," said McCowan, encouraging riders and spectators alike to come out for the ride. "This is the perfect way to end another spectacular season at the park." What makes the event so special ...

The Winner of the Web.com WNB Golf Classic Played a Graphite Design Tour AD Shaft in His Second Victory in Two Weeks

2012-09-27

Graphite Design, maker of some of the most widely played premium golf shafts on the PGA TOUR, announced today that the winner of the Web.com WNB Golf Classic played a Graphite Design Tour AD DI shaft in his driver. "The winner has been playing exceptionally well since turning pro earlier this summer," said Tak Yamada, President, Graphite Design, "This is his second victory in two weeks and we are pleased that he has chosen to play Graphite Design Tour AD shafts. We congratulate him on his victory." The winner came from five shots back, carding ...

Predicting erectile dysfunction from prostate cancer treatment

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: